BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26552470)

  • 1. Fabry disease previously diagnosed as Henoch-Schonlein purpura.
    Kim JH; Han DH; Park MY; Choi SJ; Kim JK; Hwang SD; Jin SY
    Korean J Intern Med; 2015 Nov; 30(6):925-7. PubMed ID: 26552470
    [No Abstract]   [Full Text] [Related]  

  • 2. Paradoxical Response to Enzyme Replacement Therapy of Fabry Disease Cardiomyopathy.
    Frustaci A; Russo MA; Chimenti C
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27486136
    [No Abstract]   [Full Text] [Related]  

  • 3. Anderson-Fabry disease.
    Di Toro A; Favalli V; Arbustini E
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e1-e5. PubMed ID: 29538136
    [No Abstract]   [Full Text] [Related]  

  • 4. Fabry disease: Review and experience during newborn screening.
    Hsu TR; Niu DM
    Trends Cardiovasc Med; 2018 May; 28(4):274-281. PubMed ID: 29100912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Henoch-Schönlein purpura-like presentation in IgA-dominant Staphylococcus infection - associated glomerulonephritis - a diagnostic pitfall.
    Satoskar AA; Molenda M; Scipio P; Shim R; Zirwas M; Variath RS; Brodsky SV; Nadasdy GM; Hebert L; Rovin B; Nadasdy T
    Clin Nephrol; 2013 Apr; 79(4):302-12. PubMed ID: 23320971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke and Chronic Kidney Disease in Fabry Disease.
    Tapia D; Kimonis V
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105423. PubMed ID: 33160817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage.
    Wang RY; Abe JT; Cohen AH; Wilcox WR
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S369-74. PubMed ID: 18937048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heterozygous female with Fabry disease due to a novel α-galactosidase A mutation exhibits a unique synaptopodin distribution in vacuolated podocytes.
    Takahashi N; Yokoi S; Kasuno K; Kogami A; Tsukimura T; Togawa T; Saito S; Ohno K; Hara M; Kurosawa H; Hirayama Y; Kurose T; Yokoyama Y; Mikami D; Kimura H; Naiki H; Sakuraba H; Iwano M
    Clin Nephrol; 2015 May; 83(5):301-8. PubMed ID: 25295576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Changing Landscape of Fabry Disease.
    Svarstad E; Marti HP
    Clin J Am Soc Nephrol; 2020 Apr; 15(4):569-576. PubMed ID: 32132142
    [No Abstract]   [Full Text] [Related]  

  • 10. IgA nephropathy and Henoch-Schönlein purpura nephritis.
    Sanders JT; Wyatt RJ
    Curr Opin Pediatr; 2008 Apr; 20(2):163-70. PubMed ID: 18332712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency.
    Pisani A; Visciano B; Russo R; Mozzillo GR; Porto C; De Maggio I; Russo R; Pontarelli G; Villani GR; Cianciaruso B; Di Natale P
    J Nephrol; 2012; 25(4):582-5. PubMed ID: 22307442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Petechial-like lesions, eye abnormalities, and albuminuria in a young boy.
    Roganović J
    Pediatr Dermatol; 2011; 28(6):727-728. PubMed ID: 22082470
    [No Abstract]   [Full Text] [Related]  

  • 13. Anderson-Fabry disease and the heart.
    O'Mahony C; Elliott P
    Prog Cardiovasc Dis; 2010; 52(4):326-35. PubMed ID: 20109602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What lies beneath: Fabry nephropathy in a female patient with severe cerebrovascular disease.
    Romão EA; Lourenço CM; Júnior WM; Rolfs A; Muñoz V; Vieira Neto OM; Dantas M; Silva GE; Costa RS
    Clin Nephrol; 2013 Apr; 79(4):330-4. PubMed ID: 23537685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplantation from a mother with unrecognized Fabry disease to her son with low α-galactosidase A activity: A 14-year follow-up without enzyme replacement therapy.
    Odani K; Okumi M; Honda K; Ishida H; Tanabe K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():57-9. PubMed ID: 26971403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA nephropathy and Henoch-Schönlein purpura nephritis with anterior uveitis.
    Yamabe H; Ozawa K; Fukushi K; Kubota H; Ohsawa H; Akitsu H; Chiba N; Seino S; Miyata M; Onodera K
    Nephron; 1988; 50(4):368-70. PubMed ID: 3237278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body.
    Oikawa M; Sakamoto N; Kobayashi A; Suzuki S; Yoshihisa A; Yamaki T; Nakazato K; Suzuki H; Saitoh S; Kiko Y; Nakano H; Hayashi T; Kimura A; Takeishi Y
    BMC Cardiovasc Disord; 2016 May; 16():83. PubMed ID: 27160240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic glomerulonephritis in childhood. Membranoproliferative glomerulonephritis, Henoch-Schönlein purpura nephritis, and IgA nephropathy.
    Andreoli SP
    Pediatr Clin North Am; 1995 Dec; 42(6):1487-503. PubMed ID: 8614597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.
    Maron MS; Xin W; Sims KB; Butler R; Haas TS; Rowin EJ; Desnick RJ; Maron BJ
    Am J Med; 2018 Feb; 131(2):200.e1-200.e8. PubMed ID: 28943383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The polyangiitis overlap-Schönlein-Henoch purpura-PAN syndrome: a case of more than a rare association].
    Madridano Cobo O; Sendino Revuelta A; Martínez Hernández PL; Arnalich Fernández F; Vázquez Rodríguez JJ
    An Med Interna; 1995 Apr; 12(4):195-6. PubMed ID: 7620067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.